Deputy Chief Administrative Patent Judge January 25, 2018

Slides:



Advertisements
Similar presentations
By David W. Hill AIPLA Immediate Past President Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Overview of the America Invents Act.
Advertisements

Webinar: Request for Comments on AIA Trial Proceedings Before the PTAB July 29, Scott Boalick, Vice Chief Judge (Acting) Patent Trial and Appeal.
Appeal and Postconviction Relief
© Kolisch Hartwell 2013 All Rights Reserved, Page 1 America Invents Act (AIA) Implementation in 2012 Peter D. Sabido Intellectual Property Attorney Kolisch.
Update on USPTO Activities November 18, 2014 Drew Hirshfeld Deputy Commissioner for Patent Examination Policy 1.
ARGUING YOUR APPEAL BEFORE A PANEL OF THE BPAI IN AN INTER PARTES REEXAMINATION Kevin F. Turner Administrative Patent Judge Board of Patent Appeals & Interferences.
PROSECUTION APPEALS Presented at: Webb & Co. Rehovot, Israel Date: February 14, 2013 Presented by: Roy D. Gross Associate St. Onge Steward Johnston & Reens.
Speeding It Up at the USPTO July 2013 July 23, 2013.
BIPC.COM STRATEGIC CONSIDERATIONS OF POST ISSUANCE PATENTABILITY REVIEW: THE NEW, OLD, AND NO LONGER Presented By: Todd R. Walters, Esq. B UCHANAN, I NGERSOLL.
Administrative Trials
Appeal Practice Before Board of Patent Appeals and Interferences
1 1 AIPLA Firm Logo 1 AIPLA Firm Logo American Intellectual Property Law Association CURRENT TRENDS/EFFECTS OF AIA on US Patent Practice at the US Patent.
Patent Trial and Appeal Board Update October 22, Chief Judge James Donald Smith Patent Trial and Appeal Board United States Patent and Trademark.
© 2015 Fox Rothschild Inter Partes Review Lessons Learned Scott R. Bialecki Fox Rothschild LLP June 24, 2015.
Appeal Practice Refresher Office of Patent Training.
A Comparative Analysis of Patent Post-Grant Review Procedures in the U
September 14, Final Rule Making on Practice Before the Board of Patent Appeals and Interferences (BPAI) Robert Spar Director of the Office of Patent.
Remy Yucel Director, CRU (571) Central Reexamination Unit and the AIA.
Post-Grant Proceedings Under The America Invents Act Los Angeles Intellectual Property Law Association “Washington in the West” Conference January 29,
Impact of US AIA: What Really Changed? 1 © AIPLA 2015.
1 1 AIPLA Firm Logo American Intellectual Property Law Association Update on Inter Partes Disputes and the PTAB _____ John B. Pegram Fish & Richardson.
1 1 AIPLA Firm Logo American Intellectual Property Law Association EMERGING TRENDS IN INTER PARTES REVIEW PRACTICE TOM ENGELLENNER Pepper Hamilton, LLP.
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
Post-Grant & Inter Partes Review Procedures Presented to AIPPI, Italy February 10, 2012 By Joerg-Uwe Szipl Griffin & Szipl, P.C.
Practice Before the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences.
1 Rules of Practice Before the BPAI in Ex Parte Appeals 73 Fed. Reg (June 10, 2008) Effective December 10, Fed. Reg (June 10, 2008)
1 1 AIPLA Firm Logo American Intellectual Property Law Association The Presumption of Patent Validity in the U.S. Tom Engellenner AIPLA Presentation to.
Patent Prosecution May PCT- RCE Zombie 371 National Stage PCT Applications –Not Allowed to file an RCE until signed inventor oath/declaration is.
New Ex Parte Appeal Rules Patent and Trademark Practice Group Meeting January 26, 2012.
© COPYRIGHT DICKSTEIN SHAPIRO LLP. ALL RIGHTS RESERVED. Post Grant Proceedings Before the USPTO and Litigation Strategies Under the AIA Panelists:David.
TOM ENGELLENNER Pepper Hamilton, LLP IP in Japan Committee Meeting AIPLA Annual Meeting, Washington D.C. October, 2015 USPTO Rule Changes and IPR Procedures.
Peter C. Schechter Vice-Chair, AIPPI-US Div. of AIPLA Partner, Osha Liang LLP Post-Issuance Review Proceedings: Update & Trends in IPR & PGR 1 © AIPLA.
Derivation Proceedings Gene Quinn Patent Attorney IPWatchdog.com March 27 th, 2012.
1 1 AIPLA 1 1 American Intellectual Property Law Association USPTO Post-Grant Procedures and Effective Use of Reissue AIPLA IP Practice in Japan Committee.
Appeals From AIA Trials 35 U.S.C. § 141 – Final Written Decision must be appealed to the Federal Circuit File a Notice of Appeal with the Director of the.
PTAB Litigation 2016 Part 6 – Patent Owner Response 1.
PTAB Litigation 2016 Part 7 – Petitioner Reply and Motion to Exclude 1.
Board of Patent Appeals and Interferences May 15, Interference Practice Q&A James T. Moore Administrative Patent Judge
PTAB Litigation 2016 Part 9 – Final Written Decision and Appeal 1.
PTAB Litigation 2016 Part 5 – Motions Practice, Discovery, and Trial Management Issues 1.
Recent Developments in Obtaining and Enforcing Intellectual Property Rights in Nanocomposites Michael P. Dilworth February 28, 2012.
PTAB Litigation 2016 Part 3 – The Patent Owner Preliminary Response 1.
The Applicability of Patent-Agent Privilege After In re Queen’s University at Kingston Presented by Rachel Perry © 2016 Workman Nydegger.
ptab game theory: patent owner versus petitioner
Omer/LES International/
Inter Partes Review and District Court
The America Invents Act: Five Years Later November 10, 2016 Jessica L
PTAB Litigation 2016 Part 1 – PTAB Basics and Procedure
TRADEMARK TRIAL AND APPEAL BOARD OVERVIEW
PTAB Litigation 2016 Part 12 – PTAB Popularity and Reasons
Discretionary Transfer of Cases to Tribal Court
Patent Practice in View Of PTAB AIA Proceedings
Multiple Parties and Multiple Petitions in Post-Grant Proceedings
POST Grant RevieW UPDATES
CBM/PGR Differences Differences in time periods of availability, parties who have standing, grounds of challenge available, standards of review, and.
ADVANCED PATENT LAW INSTITUTE PTAB PRACTICE AND STRATEGY
USPTO Appeal Process: Appeal Strategies and New Rules
Inter Partes Review Best Practices 2018
PTAB Bootcamp: Nuts and Bolts of IPRs, PGRs, and CBMs
Karl Renner Dorothy Whelan Chris Marchese
SSA Adverse Decisions and Administrative Finality
PTAB Litigation 2016 Part 8 – Oral Hearing
Federal Circuit control over PTAB in post-grant proceedings Fordham IP Institute Conference 2018 John Richards.
Patent Trial and Appeal Board Statistics
Update and Practical Considerations
SAS Institute v. Iancu SAS appeals arguing § 318 requires deciding patentability of all claims challenged ComlimentSoft sues SAS for patent infringement.
PTAB Litigation 2016 Part 4 – The Institution Decision
PTAB Bar Association Conference—March 2, 2017
Panel Discussion on Hearings Case Management Projects
The Other 66 Percent: Appeals Before the PTAB
Presentation transcript:

Deputy Chief Administrative Patent Judge January 25, 2018 LAIPLA Washington in the West State of the PTAB Scott Boalick Deputy Chief Administrative Patent Judge January 25, 2018

Patent Trial and Appeal Board Organizational Structure David P. Ruschke, Chief Judge Scott R. Boalick, Deputy Chief Judge Jacqueline W. Bonilla Vice Chief Judge for Operations William M. Fink Michael P. Tierney Vice Chief Judge for Operations Scott C. Weidenfeller Janet A. Gongola Vice Chief Judge for Engagement Dave Talbott Board Operations Division Board Executive

USPTO Locations (9) (12) (18) (217) (13) 4 *Alexandria, Va. count includes judges who participate in TEAPP.

Board Size Over Time (Calendar Year) 271 269 249 225 178 162 100 81 68 300 271 269 249 250 225 200 178 162 150 100 100 81 68 47 50 9 13 13 5 5 1900 1920 1940 1960 1980 1990 2000 2010 2011 2012 2013 2014 2015 2016 2017 5

Trial Statistics IPR, PGR, CBM Patent Trial and Appeal Board December 2017

Petitions by Trial Type (All Time: 9/16/12 to 12/31/17) Trial types include Inter Partes Review (IPR), Post Grant Review (PGR), and Covered Business Method (CBM).

Petitions Filed by Technology in FY18 (FY18 to date: 10/1/17 to 12/31/17)

Petitions Filed by Month (December 2017 and Previous 12 Months: 12/1/16 to 12/31/17)

Preliminary Response Filing Rates Pre- and Post-Rule To Allow New Testimonial Evidence (NTE) (All Time: 9/16/12 to 12/31/17) The rule to allow new testimonial evidence was effective May 2, 2016.

Institution Rates (FY13 to FY18: 10/1/12 to 12/31/17) Institution rate for each fiscal year is calculated by dividing petitions instituted by decisions on institution (i.e., petitions instituted plus petitions denied). The outcomes of decisions on institution responsive to requests for rehearing are excluded.

Institution Rates by Technology (All Time: 9/16/12 to 12/31/17) Institution rate for each technology is calculated by dividing petitions instituted by decisions on institution (i.e., petitions instituted plus petitions denied). The outcomes of decisions on institution responsive to requests for rehearing are excluded.

Status of Petitions (All Time: 9/16/12 to 12/31/17) These figures reflect the latest status of each petition. The outcomes of decisions on institution responsive to requests for rehearing are incorporated. Once joined to a base case, a petition remains in the Joined category regardless of subsequent outcomes.

Recent Precedential and Informative Decisions

Precedential Facebook, Inc. v. Skky, LLC Case CBM2016-00091, Paper 12 (Sept. 28, 2017) AIA § 18, pre-institution statutory disclaimer Gen. Plastic Indus. Co. v. Canon Kabushiki Kaisha Case IPR2016-01357 et al., Paper 19 (Sept. 6, 2017) AIA § 314(a), discretionary factors re: multiple petitions Ex parte McAward Appeal 2015-006416 (Aug. 25, 2017) § 112(2), indefiniteness during prosecution Athena Automation Ltd. v. Husky Injection Molding Sys. Ltd. Case IPR2013-00290, Paper 18 (Oct. 25, 2013) AIA § 311(a), assignor estoppel 9/16/2018

Informative Luv N’ Care, Ltd. v. McGinley Case IPR2017-01216, Paper 13 (Sept. 18, 2017) AIA § 315(b), insufficient funds at filing Amneal Pharmaceuticals, LLC. v. Endo Pharmaceuticals Inc. Case IPR2014-00360, Paper 15 (June 27, 2014) AIA § 315(b), district court motion to amend complaint Cultec, Inc. v. Stormtech LLC Case IPR2017-00777, Paper 7 (Aug. 22, 2017) AIA § 325(d), deny institution – examination 9/16/2018

Informative (continued) Hospira, Inc. v. Genentech, Inc. Case IPR2017-00739, Paper 16 (July 27, 2017) AIA § 325(d), deny institution – examination Unified Patents Inc. v. Berman Case IPR2016-01571, Paper 10 (Dec. 14, 2016) 9/16/2018

Updated Precedential and Informative Decision Website Accessible via the public PTAB Website at the following address: https://www.uspto.gov/patents-application-process/patent-trial-and-appeal-board/precedential-informative-decisions

Motions to Amend and Aqua Products

In re Aqua Products: Procedural History October 23, 2014 – Original appeal of IPR2013-00159 (Paper 71) (PTAB Aug. 22, 2014) Board denied Aqua’s motion to substitute claims 22–24, which proposed to amend claims 1, 8, and 20 to include additional limitations May 25, 2016 – Federal Circuit (Prost, Reyna, Stark) affirmed Board decision, citing prior court decisions August 12, 2016 – Federal Circuit ordered rehearing en banc in relation to two questions

In re Aqua Products (order granting rehearing en banc) Questions for appellant and USPTO intervenor: Q1: When PO moves to amend claims under 35 U.S.C. § 316(d), may PTO require PO to bear the burden of persuasion, or a burden of production, regarding patentability of amended claims as a condition of allowing them? Which burdens are permitted under 35 U.S.C. § 316(e)? Q2: When petitioner does not challenge the patentability of a proposed amended claim, or the Board thinks the challenge is inadequate, may the Board sua sponte raise patentability challenges to such a claim? If so, where would the burden of persuasion, or a burden of production, lie?

In re Aqua Products October 4, 2017 – Federal Circuit issued en banc decision, which included five separate opinions As noted in lead opinion: “[V]ery little said over the course of the many pages that form the five opinions in this case has precedential weight.” “The only legal conclusions that support and define the judgment of the court are: (1) the PTO has not adopted a rule placing the burden of persuasion with respect to the patentability of amended claims on the patent owner that is entitled to deference; and (2) in the absence of anything that might be entitled deference, the PTO may not place that burden on the patentee.” November 21, 2017 – PTAB Chief Judge issued Guidance in view of Aqua Products decision

Guidance on Motions to Amend in view of Aqua Products Board will not place the burden of persuasion on PO with respect to the patentability of substitute claims presented in a motion to amend; If PO files a motion to amend, Board will determine whether the substitute claims are unpatentable by a preponderance of the evidence based on the entirety of the record, including any opposition made by the petitioner; Practice and procedure before Board will not change.

Guidance on Motions to Amend in view of Aqua Products A motion to amend must meet requirements of 35 U.S.C. § 316(d) propose a reasonable number of substitute claims substitute claims do not enlarge scope of the original claims or introduce new matter A motion to amend must meet requirements of 37 C.F.R. § 42.121 or § 42.221, as applicable set forth written description support and support for benefit of a filing date in relation to each substitute claim respond to grounds of unpatentability involved in the trial Under 37 C.F.R. § 42.11, all parties have a duty of candor including PO’s duty to disclose information that PO is aware of that is material to the patentability of substitute claims, if such information is not already of record

Guidance on Motions to Amend in view of Aqua Products Board will continue its current briefing practice as to types, timing, and page-limits of briefs; Parties with pending motions to amend may request briefing changes or additional briefing; PO may contact the Board to file new or substitute motion to amend under certain circumstances. 

SOP 9 on Remands

Changes to SOP 9 Goal of issuing remand decisions within 6 month Meeting with the Chief, Deputy Chief, or their delegates Establishes default procedures for trial and appeal remand scenarios

Default Trial Procedures for Common Remand Scenarios Additional Briefing? Additional Evidence? Oral Argument? 1 Erroneous claim interpretation Yes, unless the claim interpretation to be applied on remand was proposed by one of the parties and the effect has been fully briefed No, unless evidence of record is insufficient to afford due process No 2 Failure to consider the evidence Yes, unless the evidence was fully briefed on the record 3 Inadequate explanation by the Board No, unless the briefing on the issues is inadequate for the Board to have made a decision in the first instance 4 Erroneous application of law Yes, unless the law was fully briefed on the record but not reflected in Board decision 5 Law of due process/denial of APA rights Yes Yes, for parties whose rights have been violated, unless additional briefing on evidence of record is sufficient to afford due process Yes, if necessary to afford due process 6 Improper consideration of the arguments Yes, unless argument is fully briefed in the record

Prosecution/Reexamination Reopened Remand Scenario Prosecution/Reexamination Reopened 1 Erroneous claim interpretation No, unless alternative claim interpretation renders the present rejection(s) moot 2 Failure to consider the evidence No, unless the evidence of record is deemed entirely insufficient to support the present rejection(s) 3 Inadequate explanation by the Board No, the Board provides additional explanation or reverse on the present record 4 Erroneous application of law No, unless the correct application of the law renders the present rejection(s) moot 5 Law of due process/denial of APA rights Yes, typically in the form of a new ground of rejection 6 Improper consideration of the arguments No, arguments that were not sufficiently briefed before the Board are deemed waived

Accessible via the public PTAB Website at the following address: https://public.govdelivery.com/accounts/USPTO/subscriber/new

Deputy Chief Administrative Patent Judge (571) 272-9797 Questions and Comments Scott Boalick Deputy Chief Administrative Patent Judge (571) 272-9797 Scott.Boalick@uspto.gov

Additional Information

An Analysis of Multiple Petitions in AIA Trials

Jurisdiction of Patent Challenges District Court PTAB Jurisdiction of Patent Challenge Approximately 85% of IPRs in Fiscal Year 2017 have a co-pending district court case Less than a fifth of district court cases involve patents that are challenged in an IPR Data sourced from Lex Machina PTAB Report 2017

Multiple Petition Study Petitioners Per Patent No. of Petitioners vs. Patent No. of Patents % Patents 1 3711 84.8% 2 424 9.7% 3 132 3.0% 4 59 1.3% 5 28 0.6% 6 17 0.4% 7 <0.1% 8 Total 4376 100% Data Through 6/30/17 Percentages may not add to 100% due to rounding

Multiple Petition Study No. of Petitions per Patent Patents % of Total 1 2932 67.0% 2 885 20.2% 3 256 5.9% 4 142 3.2% 5 54 1.2% 6 52 7 or more 55 1.3% Total 4376 100% Data Through 6/30/17

When Petitions Are Filed “POPR” “DI” “FWD” Before POPR Before DI After DI

Multiple Petition Study Who are post-DI Petitioners? 9-10% of petitions filed by: Defendant-Petitioner; or Same or Different Petitioner Filing due to a change in litigation; or Seeking to join existing trial as a party 16% of all petitions are filed after a DI A random sample of the 1054 petitions filed after DI as of 3/1/17* was taken The sample included 169 petitions, and the results were found to be statistically significant, such that we can use the sample (169 petitions) as an estimate of the whole (1054 petitions). 16% 6-7% of petitions filed by: Non-Defendant Petitioner; or Same Petitioner Filing not due to change in litigation; and Not seeking party joinder *Random sample taken on 3/1/17 using data through 2/28/17

Multiple Petition Study Rounds of Petitions 95% of petitions are filed in a given petitioner’s first round A “round” is all petitions filed before receiving a DI on one of those petitions Rounds of Petitions No. of Petitions % of Petitions First Round of Petitions 6481 95% Second Round of Petitions 369 5% Third or Fourth Round of Petitions 7 <0.1% Total 6857* 95% of petitions are filed in a given Petitioner’s first round 95% of a Given Petitioner’s Petitions are filed in One Round Data Through 6/30/17 *Not included are 311 Petitions filed where a request to join as a party to another proceeding was granted

Multiple Petition Study Institution Rate Institution rate as measured by patent is only slightly higher than the institution rate as measured by petition “By patent” accounts for whether any one petition against particular patent is instituted Example against Patent A: Petition 1 instituted Petition 2 not instituted Net result = 100% institution rate “By petition” accounts for whether a particular petition was instituted; publicly reported monthly Example against Patent A Net result = 50% institution rate 42 Data Through 6/30/17

Status of Petitions (All Time: 9/16/12 to 12/31/17) These figures reflect the latest status of each petition. The outcomes of decisions on institution responsive to requests for rehearing are incorporated. Once joined to a base case, a petition remains in the Joined category regardless of subsequent outcomes.

Multiple Petition Study Ultimate Outcome 69% of all petitions result in a patent being unchanged; 58% of patents are unchanged at the end of one or more AIA proceedings “By patent” accounts for whether any one petition against particular patent results in any unpatenable claims “By petition” accounts for whether a particular petition results in any unpatentable claims Data Through 6/30/17

Multiple Petition Study Highlights Studied: 7168 petitions addressing 4376 patents Who: 84.8% of patents are challenged by a single petitioner What: 87% of patents are challenged by 1 or 2 petitions Where: 85% of IPRs have a co-pending district court case When: 79% of petitions are filed before any Patent Owner Response or a Decision on Institution 95% of petitions are filed in a given petitioner’s first round Why: Often a petitioner could not have filed a petition earlier or may be prompted to file later because of the litigation circumstances How: Institution rate by patent (FY17: 70%) is only slightly higher than by petition (FY17: 64%) 58% of patents challenged at the PTAB are unchanged

Motion to Amend Study

Motion to Amend Study Data current as of: 9/30/2017